Medipal Holdings Corp
TSE:7459
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medipal Holdings Corp
Free Cash Flow
Medipal Holdings Corp
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Medipal Holdings Corp
TSE:7459
|
Free Cash Flow
¥34.1B
|
CAGR 3-Years
44%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alfresa Holdings Corp
TSE:2784
|
Free Cash Flow
¥8.3B
|
CAGR 3-Years
58%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-1%
|
|
|
Toho Holdings Co Ltd
TSE:8129
|
Free Cash Flow
¥4B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-7%
|
|
|
Suzuken Co Ltd
TSE:9987
|
Free Cash Flow
¥1.5B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-21%
|
|
|
Ship Healthcare Holdings Inc
TSE:3360
|
Free Cash Flow
¥21.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
29%
|
CAGR 10-Years
11%
|
|
|
As One Corp
TSE:7476
|
Free Cash Flow
¥6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
28%
|
CAGR 10-Years
5%
|
|
Medipal Holdings Corp
Glance View
Medipal Holdings Corp., a longstanding pillar in Japan’s healthcare and pharmaceutical distribution network, tells a story of efficiency and dedication to health. Born from a strategic merger in the late 20th century, Medipal has established itself as a key player in the intricate world of pharmaceutical and medical supply logistics. The company's operations are woven into the fabric of Japan’s healthcare infrastructure, where precision and reliability form the foundation of its success. By orchestrating the smooth flow of pharmaceuticals, medical devices, and health-related products from manufacturers to a myriad of healthcare facilities and retail outlets, Medipal plays a vital role in ensuring that medical professionals and patients alike have timely access to necessary products. At the heart of Medipal's business model is a comprehensive supply chain that seamlessly connects an extensive network of partners. With sophisticated distribution centers operating as logistical powerhouses, Medipal leverages cutting-edge technology to optimize inventory management and delivery systems. This enables the company not only to drive efficiencies but also to create value by reducing costs and enhancing the speed and reliability of distributions. Revenue streams are generated primarily through distribution fees and the strategic management of logistics services. As Medipal continues to expand its reach and refine its operations, it remains steadfast in its commitment to being an indispensable ally in Japan's healthcare landscape, where reliability and trust are of paramount importance.
See Also
What is Medipal Holdings Corp's Free Cash Flow?
Free Cash Flow
34.1B
JPY
Based on the financial report for Dec 31, 2025, Medipal Holdings Corp's Free Cash Flow amounts to 34.1B JPY.
What is Medipal Holdings Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-10%
Over the last year, the Free Cash Flow growth was -40%. The average annual Free Cash Flow growth rates for Medipal Holdings Corp have been 44% over the past three years , -10% over the past five years .